A European study's preliminary findings suggest that psoriasis treatments with Daivobet® gel (calcipotriol/betamethasone dipropionate, LEO-Pharma) result in significant improvement in disease severity and patient preference. » See preliminary findings
Responses to a recent survey indicate that the public's perception of what dermatologists actually do falls significantly short of reality. » Public perceptions
New research looking at the psychological impact from psoriasis reveals key themes about how the skin disease affects people's identity and relationships. » Messages underscore need for patients support
A Pittsburgh-based national health insurance provider will be the first health insurer in the U.S. to cover teledermatology. The company will begin reimbursing for online services provided through DermatologistOnCall Jan. 1, 2015. » A new opportunity for expanding patient choice
Like
Tweet
